Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwin Bischoff

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Circulation|September 24, 2004
Effects of the sGC stimulator BAY 41-2272 are not mediated by phosphodiesterase 5 inhibitionErwin Bischoff, Johannes-Peter Stasch
Progress in Medicinal Chemistry|May 31, 2003
Phosphodiesterase type 5 (PDE5) inhibitorsHelmut Haning, Ulrich Niewöhner, Erwin Bischoff
Handbook of Experimental Pharmacology|December 18, 2008
Erectile dysfunction and lower urinary tractPeter Sandner, Dieter Neuser, Erwin Bischoff
Handbook of Experimental Pharmacology|December 18, 2008
Cyclic GMP-hydrolyzing phosphodiesterasesSharron H Francis, Jackie D Corbin, Erwin Bischoff
Archiv Der Pharmazie|June 10, 2004
New antithrombotics with an indazole structureAli Kemal Yildiz, Klaus Rehse, Johannes-Peter Stasch, et al.
Archiv Der Pharmazie|December 17, 2003
New antithrombotic 1-phthalazinamines with serotonin antagonistic propertiesMatthias Johnsen, Klaus Rehse, Heinz Pertz, et al.
The Journal of Sexual Medicine|November 15, 2006
Antidepressant-induced inhibition of genital vascular responses is reversed by vardenafil in female rabbitsJavier Angulo, Pedro Cuevas, Begona Cuevas, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2005
Comparison of different heterocyclic scaffolds as substrate analog PDE5 inhibitorsHelmut Haning, Ulrich Niewöhner, Thomas Schenke, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2002
Imidazo[5,1-f]triazin-4(3H)-ones, a new class of potent PDE 5 inhibitorsHelmut Haning, Ulrich Niewöhner, Thomas Schenke, et al.
Journal of Andrology|May 11, 2002
Efficacy of vardenafil and sildenafil in facilitating penile erection in an animal modelSeong Choi, Luke O'Connell, Kweonsik Min, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Circulation|September 24, 2004
Effects of the sGC stimulator BAY 41-2272 are not mediated by phosphodiesterase 5 inhibitionErwin Bischoff, Johannes-Peter Stasch
Progress in Medicinal Chemistry|May 31, 2003
Phosphodiesterase type 5 (PDE5) inhibitorsHelmut Haning, Ulrich Niewöhner, Erwin Bischoff
Handbook of Experimental Pharmacology|December 18, 2008
Erectile dysfunction and lower urinary tractPeter Sandner, Dieter Neuser, Erwin Bischoff
Handbook of Experimental Pharmacology|December 18, 2008
Cyclic GMP-hydrolyzing phosphodiesterasesSharron H Francis, Jackie D Corbin, Erwin Bischoff
Archiv Der Pharmazie|June 10, 2004
New antithrombotics with an indazole structureAli Kemal Yildiz, Klaus Rehse, Johannes-Peter Stasch, et al.
Archiv Der Pharmazie|December 17, 2003
New antithrombotic 1-phthalazinamines with serotonin antagonistic propertiesMatthias Johnsen, Klaus Rehse, Heinz Pertz, et al.
The Journal of Sexual Medicine|November 15, 2006
Antidepressant-induced inhibition of genital vascular responses is reversed by vardenafil in female rabbitsJavier Angulo, Pedro Cuevas, Begona Cuevas, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2005
Comparison of different heterocyclic scaffolds as substrate analog PDE5 inhibitorsHelmut Haning, Ulrich Niewöhner, Thomas Schenke, et al.
Bioorganic & Medicinal Chemistry Letters|April 18, 2002
Imidazo[5,1-f]triazin-4(3H)-ones, a new class of potent PDE 5 inhibitorsHelmut Haning, Ulrich Niewöhner, Thomas Schenke, et al.
Journal of Andrology|May 11, 2002
Efficacy of vardenafil and sildenafil in facilitating penile erection in an animal modelSeong Choi, Luke O'Connell, Kweonsik Min, et al.
Pageof 2